102 related articles for article (PubMed ID: 1476858)
1. Enantioselective pharmacodynamics of the nonsteroidal antiinflammatory drug ketoprofen: in vitro inhibition of human platelet cyclooxygenase activity.
Hayball PJ; Nation RL; Bochner F
Chirality; 1992; 4(8):484-7. PubMed ID: 1476858
[TBL] [Abstract][Full Text] [Related]
2. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.
Hayball PJ; Nation RL; Bochner F; Sansom LN; Ahern MJ; Smith MD
Br J Clin Pharmacol; 1993 Sep; 36(3):185-93. PubMed ID: 9114902
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofen.
Suesa N; Fernandez MF; Gutierrez M; Rufat MJ; Rotllan E; Calvo L; Mauleon D; Carganico G
Chirality; 1993; 5(8):589-95. PubMed ID: 8305286
[TBL] [Abstract][Full Text] [Related]
4. Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.
Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
Br J Clin Pharmacol; 1991 Feb; 31(2):131-8. PubMed ID: 1904749
[TBL] [Abstract][Full Text] [Related]
5. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases.
Neupert W; Brugger R; Euchenhofer C; Brune K; Geisslinger G
Br J Pharmacol; 1997 Oct; 122(3):487-92. PubMed ID: 9351505
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves.
Landoni MF; Lees P
Chirality; 1995; 7(8):586-97. PubMed ID: 8593252
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective inhibition of rat brain cyclooxygenase by dexketoprofen.
Carabaza A; Cabré F; García AM; Rotllan E; García ML; Mauleón D
Chirality; 1997; 9(3):281-5. PubMed ID: 9176993
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein binding of ketoprofen enantiomers in man: method development and its application.
Hayball PJ; Nation RL; Bochner F; Newton JL; Massy-Westropp RA; Hamon DP
Chirality; 1991; 3(6):460-6. PubMed ID: 1812956
[TBL] [Abstract][Full Text] [Related]
11. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
13. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases.
Panara MR; Greco A; Santini G; Sciulli MG; Rotondo MT; Padovano R; di Giamberardino M; Cipollone F; Cuccurullo F; Patrono C
Br J Pharmacol; 1995 Nov; 116(5):2429-34. PubMed ID: 8581280
[TBL] [Abstract][Full Text] [Related]
14. A prostacyclin-sparing effect of indobufen vs. aspirin.
De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat.
Arifah AK; Landoni MF; Lees P
J Vet Pharmacol Ther; 2003 Apr; 26(2):139-50. PubMed ID: 12667184
[TBL] [Abstract][Full Text] [Related]
16. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep.
Arifah AK; Landoni MF; Frean SP; Lees P
Am J Vet Res; 2001 Jan; 62(1):77-86. PubMed ID: 11197566
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical development of dexketoprofen.
Mauleón D; Artigas R; García ML; Carganico G
Drugs; 1996; 52 Suppl 5():24-45; discussion 45-6. PubMed ID: 8922555
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiplatelet activity of the carbinol analogue of ketoprofen, 3-(1-methyl-2-hydroxyethyl)-benzophenone.
Oshima K; Hashizume H; Miyamae T; Morikawa T; Hagiwara M
Arzneimittelforschung; 1996 Jul; 46(7):691-3. PubMed ID: 8842339
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man.
Depré M; Van Hecken A; Verbesselt R; De Lepeleire I; Schwartz J; Porras A; Larson P; Lin C; De Schepper PJ
Int J Clin Pharmacol Res; 1998; 18(2):53-61. PubMed ID: 9675622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
